Abstract
Over the past several years GSK has been developing the capability to perform continuous hydrogenations within trickle bed reactors. Motivation to develop this technology stems from the ability of ...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
